CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients

CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients

Abstract Background Early detection of capecitabine-resistance could largely increase overall survival of colorectal cancer (CRC) patients. Previous studies suggested examination of immune cells in peripheral blood would help to predict efficacy of chemotherapy. Methods We examined the immunological...

Full description

Bibliographic Details
Main Authors: Yu Lu, Yizhou Huang, Lei Huang, Yanjie Xu, Zien Wang, Han Li, Ting Zhang, Ming Zhong, Wei-qiang Gao, Yan Zhang
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Immunology
Subjects:
CD16
Neutrophils
Capecitabine-resistance
Colorectal cancer
Online Access:http://link.springer.com/article/10.1186/s12865-020-00375-8

Internet

http://link.springer.com/article/10.1186/s12865-020-00375-8

Similar Items